MedPath

Cost-effectiveness of the demands and capacities model-based treatment compared to the Lidcombe Programme of early stuttering intervention: a randomised trial (the Rotterdam Evaluation study of Stuttering Treatment in children- A Randomized Trial)

Not Applicable
Completed
Conditions
Stuttering pre-schoolers
Mental and Behavioural Disorders
Behavioural and emotional disorders
Registration Number
ISRCTN24362190
Lead Sponsor
Erasmus Medical Centre (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
196
Inclusion Criteria

1. Aged 3.0 to 6.3 years
2. Frequency of stuttering at least 3%
3. Parent and one therapist agree the child stutters
4. Parent rating of stuttering severity on an 8-point scale of at least 2
5. Proficiency in Dutch for children and parents

Exclusion Criteria

1. Onset of stuttering within 6 months before recruitment
2. Treatment for stuttering during the previous 12 months
3. Diagnosed language disorder
4. Neurological, emotional, cognitive, behavioural or autism spectrum disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. The percentage of recovered children at 18 months post randomisation<br>2. The costs for a recovered child<br>All primary outcome measures will be measured at 3, 6, 12 and 18 months post starting the therapy.
Secondary Outcome Measures
NameTimeMethod
1. The frequency of stuttering outside the clinic at 18 months post randomisation<br>2. The Health Utility Index<br>3. Visual Analogue Scale (Euroqol VAS proxy)<br>4. Child Health Questionnaire<br>5. Children Behaviour Check List<br>All secondary outcome measures will be measured at 3, 6, 12 and 18 months post starting the therapy, except the Children Behavioural Check List, which will be measured at 18 months only.
© Copyright 2025. All Rights Reserved by MedPath